US HB2113 | 2019-2020 | 116th Congress

Status

Spectrum: Strong Partisan Bill (Democrat 10-1)
Status: Introduced on April 8 2019 - 25% progression
Action: 2019-04-08 - Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Pending: House Ways And Means Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Prescription Drug STAR Act Prescription Drug Sunshine, Transparency, Accountability and Reporting Act

Tracking Information

Register now for our free OneVote public service or GAITS Professional trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Prescription Drug STAR Act Prescription Drug Sunshine, Transparency, Accountability and Reporting Act

Sponsors


History

DateChamberAction
2019-04-08HouseReferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-04-08HouseReferred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2019-04-08HouseReferred to the Subcommittee on Health.
2019-04-08HouseIntroduced in House

Same As/Similar To

HB2087 (Related) 2019-05-21 - Subcommittee Hearings Held.
HB2069 (Related) 2019-05-21 - Subcommittee Hearings Held.
HB2115 (Related) 2019-05-21 - Subcommittee Hearings Held.
SB2051 (Related) 2019-06-28 - Read twice and referred to the Committee on Finance.

Subjects


US Congress State Sources


Bill Comments

feedback